Exact Mass: 318.1215658
Exact Mass Matches: 318.1215658
Found 140 metabolites which its exact mass value is equals to given mass value 318.1215658,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Tebupirimfos
CONFIDENCE standard compound; INTERNAL_ID 1225; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10232; ORIGINAL_PRECURSOR_SCAN_NO 10230 CONFIDENCE standard compound; INTERNAL_ID 1225; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10218; ORIGINAL_PRECURSOR_SCAN_NO 10216 CONFIDENCE standard compound; INTERNAL_ID 1225; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10254; ORIGINAL_PRECURSOR_SCAN_NO 10252 CONFIDENCE standard compound; INTERNAL_ID 1225; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10208; ORIGINAL_PRECURSOR_SCAN_NO 10207 CONFIDENCE standard compound; INTERNAL_ID 1225; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10252; ORIGINAL_PRECURSOR_SCAN_NO 10250 CONFIDENCE standard compound; INTERNAL_ID 1225; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10257; ORIGINAL_PRECURSOR_SCAN_NO 10256
fluvoxamino acid
fluvoxamino acid is a metabolite of fluvoxamine. Fluvoxamine (brand name Luvox) is an antidepressant which functions as a selective serotonin reuptake inhibitor (SSRI). Fluvoxamine was first approved by the U.S. Food and Drug Administration (FDA) in 1993 for the treatment of obsessive compulsive disorder (OCD). Fluvoxamine CR (controlled release) is approved to treat social anxiety disorder. (Wikipedia)
2-O-??-D-Glucopyranoside-4-Hydroxy-4-(2-hdyroxyethyl)-2-cyclohexen-1-one
(1aS,3R,4R,4aR,6S,7R,8aS)-7-chloro-3,6-dihydroxy-3,4a,8,8-tetramethyl-octahydro-1aH-naphtho[1-b]oxirene-4-carboxylic acid
9-(2-Thienyl)-non-6-en-8-in-4-ol-3-on-isovalerat
C18H22O3S (318.12895820000006)
9-(2-Thienyl)-non-6-en-8-in-5-ol-3-on-isovalerat
C18H22O3S (318.12895820000006)
Ala Asp Gly Gly
Ala Gly Asp Gly
Asp Ala Gly Gly
Asp Gly Ala Gly
Asp Gly Gly Ala
Glu Gly Gly Gly
Gly Ala Asp Gly
Gly Asp Ala Gly
Gly Asp Gly Ala
Gly Glu Gly Gly
Gly Gly Asp Ala
(2E,6E)-2,6-bis(2-phenylhydrazono)cyclohex-4-ene-1,3-dione
methyl 1-(2,2-dimethoxyethyl)-6-oxo-2-phenylpyrimidine-5-carboxylate
3-Pyridazinecarboxylic acid, 6-(4-fluoro-2-methylphenyl)-, 2-(methoxyacetyl)hydrazide
(S)-5-AMINO-2-(BENZYLOXYCARBONYLAMINO)PENTANOIC ACID
(9H-FLUOREN-9-YL)METHYL 2,3-DIAMINOPROPANOATE HYDROCHLORIDE
C17H19ClN2O2 (318.11349839999997)
6-(4-methoxyphenyl)-5-pyridin-3-ylfuro[2,3-d]pyrimidin-4-amine
4-(5-ethyl-2,4,6-trioxo-5-phenyl-1,3-diazinan-1-yl)butanoic acid
N-(3-methoxyphenyl)-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amine
3-(3,5-DIMETHOXYPHENYL)-1-(2-NAPHTHYL)PROP-2-EN-1-ONE
METHYL 6-N-BOC-AMINO-3-FORMYL-1H-INDOLE-4-CARBOXYLATE
[2-[2-(2-METHOXYETHOXY)ETHOXY]ETHOXY] P&
C14H22O6S (318.11370320000003)
Benzoic acid,4-(phenylmethoxy)-, phenylmethyl ester
N,N-Di-t-butyl-2,3-diaMidobutanetin(II), 98\\%, 50-1150, contained in 50 Ml Swagelok cylinder (96-1070) for CVD/ALD
C12H26N2Sn (318.11178659999996)
(2S)-2-(biphenyl-4-yloxy)-3-phenylpropanoic acid
LT175, a dual PPARα/γ ligand, is an orally active partial agonist against PPARγ(hPPARα:EC50=0.22 μm; mPPARα:EC50=0.26 μm; hPPARγ:EC50=0.48 μm). LT175 interacts with PPARγ and affects the recruitment of the coregulators cyclic-AMP response element-binding protein-binding protein and nuclear corepressor 1 (NCoR1). LT175 interacts with PPARγ in a hydrophobic region called “diphenyl pocket”. LT175 has potent insulin-sensitizing effects and reduced adipogenic properties[1].
3-(6-Benzyloxy-naphthalen-2-yl)-acrylic acid methyl ester
(2E,6E)-2,6-bis(phenylhydrazinylidene)cyclohex-4-ene-1,3-dione
2-(4-Hydroxy-5-phenyl-1H-pyrazol-3-YL)-1H-benzoimidazole-5-carboxamidine
2-[1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-oxo-2-sulfanylidenepyrimidin-5-yl]ethyl-methylazanium
5-[(3,4-Dimethoxyphenyl)methyl]-1-prop-2-enyl-1,3-diazinane-2,4,6-trione
[5-(2,5-Dimethoxyphenyl)-3-isoxazolyl]-(4-morpholinyl)methanone
Ethyl 4-[4-methyl-6-(trifluoromethyl)pyrimidin-2-yl]piperazine-1-carboxylate
C13H17F3N4O2 (318.13035379999997)
2-[2-(Difluoromethoxy)anilino]-1-(2,3-dihydroindol-1-yl)ethanone
C17H16F2N2O2 (318.11797799999994)
3-(1-Azepanyl)-4-chloro-1-(2-methylphenyl)pyrrole-2,5-dione
C17H19ClN2O2 (318.11349839999997)
[4-(3-Chlorophenyl)-1-piperazinyl]-(2,5-dimethyl-3-furanyl)methanone
C17H19ClN2O2 (318.11349839999997)
N-methyl-6-chloro-1-(3-methylphenyl)-2,3,4,5-tetrahydro-3-benzazepinium-7,8-diol(1+)
C18H21ClNO2+ (318.12607360000004)
gamma-D-glutamyl-meso-diaminoheptanedioate
C12H20N3O7- (318.13011900000004)
3-(4-Hydroxyphenyl)-9-methyl-5,9-diaza-14-azoniatetracyclo[6.6.1.02,6.011,15]pentadeca-1(14),2(6),3,8(15),10-pentaen-7-one
Triethyl 2-carboxymethyl-1,2,3-propane-tricarboxylate
(2r,3r)-3-hydroxy-2-(hydroxymethyl)-4-methoxy-4-oxobutyl (2e,4s,5s,6e)-4,5-dihydroxyocta-2,6-dienoate
(6r)-6-[(2s)-2-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propyl]-5,6-dihydropyran-2-one
5-(chloromethyl)-5-hydroxy-6-(hydroxymethyl)-6-[2-methyl-3-(3-methylbut-2-en-1-yl)oxiran-2-yl]oxan-2-one
20-imino-2,12,15-triazapentacyclo[11.7.1.0³,⁸.0⁹,²¹.0¹⁴,¹⁹]henicosa-1,3(8),4,6,9(21),10,12,14(19)-octaene-6,18-diol
{[(4r,6r,12s)-6-hydroxy-12-methyl-2,5-dioxo-1-oxacyclododecan-4-yl]sulfanyl}acetic acid
C14H22O6S (318.11370320000003)
3-hydroxy-2-(hydroxymethyl)-4-methoxy-4-oxobutyl 4,5-dihydroxyocta-2,6-dienoate
(4r)-4-hydroxy-4-(2-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}ethyl)cyclohex-2-en-1-one
7-oxo-1-(thiophen-2-yl)non-3-en-1-yn-5-yl 3-methylbutanoate
C18H22O3S (318.12895820000006)
7-chloro-3,6-dihydroxy-3,4a,8,8-tetramethyl-hexahydronaphtho[1,8a-b]oxirene-4-carboxylic acid
8-[(4-hydroxyphenyl)methyl]-9,10-dihydrophenanthrene-2,5-diol
[(6-hydroxy-12-methyl-2,5-dioxo-1-oxacyclododecan-4-yl)sulfanyl]acetic acid
C14H22O6S (318.11370320000003)
(3e,5r)-7-oxo-1-(thiophen-2-yl)non-3-en-1-yn-5-yl 3-methylbutanoate
C18H22O3S (318.12895820000006)
(4s,6e)-3-oxo-9-(thiophen-2-yl)non-6-en-8-yn-4-yl 3-methylbutanoate
C18H22O3S (318.12895820000006)
(1as,3r,4r,4ar,6s,7r,8as)-7-chloro-3,6-dihydroxy-3,4a,8,8-tetramethyl-hexahydronaphtho[1,8a-b]oxirene-4-carboxylic acid
4-hydroxy-4-(2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}ethyl)cyclohex-2-en-1-one
8-[2-hydroxy-5-(prop-2-en-1-yl)phenyl]-6-(prop-2-en-1-yl)chromen-2-one
3-oxo-9-(thiophen-2-yl)non-6-en-8-yn-4-yl 3-methylbutanoate
C18H22O3S (318.12895820000006)